Clinical Trials Browser

Interventional × Uterine Cervical Neoplasms × Platinum Compounds × Clear all

NCT04906993 2025-09-09

Camrelizumab Combined With Famitinib Malate for Treatment of Recurrent/Metastatic Cervical Cancer

Phase 3 Active not recruiting

Uterine Cervical Neoplasms

NCT06986057 2025-05-22

Iparomlimab and Tuvonralimab Combined With Platinum-Based Chemotherapy for Neoadjuvant Treatment of Cervical Cancer

Phase 2 Not yet recruiting

Uterine Cervical Neoplasms